Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Roberto Chiarelli

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Molecules (Basel, Switzerland)|March 19, 2020
Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant TuberculosisGiovanni Stelitano, José Camilla Sammartino, Laurent Roberto Chiarelli
International Journal of Molecular Sciences|November 26, 2022
New Drugs and Novel Cellular Targets against TuberculosisGiulia Degiacomi, Vadim Makarov, Maria Rosalia Pasca, et al.
Drug Discovery Today|September 22, 2016
New prodrugs against tuberculosisGiorgia Mori, Laurent Roberto Chiarelli, Giovanna Riccardi, et al.
Blood Reviews|March 16, 2007
Pyruvate kinase deficiency: the genotype-phenotype associationAlberto Zanella, Elisa Fermo, Paola Bianchi, et al.
International Journal of Molecular Sciences|April 13, 2023
Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?Giovanni Stelitano, Mario Cocorullo, Matteo Mori, et al.
Current Medicinal Chemistry|September 27, 2016
New and Old Hot Drug Targets in TuberculosisLaurent Roberto Chiarelli, Giorgia Mori, Marta Esposito, et al.
European Journal of Medicinal Chemistry|August 16, 2021
Natural products against key Mycobacterium tuberculosis enzymatic targets: Emerging opportunities for drug discoveryGiulia Cazzaniga, Matteo Mori, Laurent Roberto Chiarelli, et al.
Applied Microbiology and Biotechnology|September 17, 2013
The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosisGiovanna Riccardi, Maria Rosalia Pasca, Laurent Roberto Chiarelli, et al.
Biochemical and Biophysical Research Communications|April 2, 2022
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complexJosè Camilla Sammartino, Martino Morici, Giovanni Stelitano, et al.
International Journal of Molecular Sciences|November 27, 2019
<i>Mycobacterium abscessus</i>, an Emerging and Worrisome Pathogen among Cystic Fibrosis PatientsGiulia Degiacomi, José Camilla Sammartino, Laurent Roberto Chiarelli, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Molecules (Basel, Switzerland)|March 19, 2020
Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant TuberculosisGiovanni Stelitano, José Camilla Sammartino, Laurent Roberto Chiarelli
International Journal of Molecular Sciences|November 26, 2022
New Drugs and Novel Cellular Targets against TuberculosisGiulia Degiacomi, Vadim Makarov, Maria Rosalia Pasca, et al.
Drug Discovery Today|September 22, 2016
New prodrugs against tuberculosisGiorgia Mori, Laurent Roberto Chiarelli, Giovanna Riccardi, et al.
Blood Reviews|March 16, 2007
Pyruvate kinase deficiency: the genotype-phenotype associationAlberto Zanella, Elisa Fermo, Paola Bianchi, et al.
International Journal of Molecular Sciences|April 13, 2023
Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?Giovanni Stelitano, Mario Cocorullo, Matteo Mori, et al.
Current Medicinal Chemistry|September 27, 2016
New and Old Hot Drug Targets in TuberculosisLaurent Roberto Chiarelli, Giorgia Mori, Marta Esposito, et al.
European Journal of Medicinal Chemistry|August 16, 2021
Natural products against key Mycobacterium tuberculosis enzymatic targets: Emerging opportunities for drug discoveryGiulia Cazzaniga, Matteo Mori, Laurent Roberto Chiarelli, et al.
Applied Microbiology and Biotechnology|September 17, 2013
The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosisGiovanna Riccardi, Maria Rosalia Pasca, Laurent Roberto Chiarelli, et al.
Biochemical and Biophysical Research Communications|April 2, 2022
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complexJosè Camilla Sammartino, Martino Morici, Giovanni Stelitano, et al.
International Journal of Molecular Sciences|November 27, 2019
<i>Mycobacterium abscessus</i>, an Emerging and Worrisome Pathogen among Cystic Fibrosis PatientsGiulia Degiacomi, José Camilla Sammartino, Laurent Roberto Chiarelli, et al.
Pageof 3